SLC25A46 mutations in patients with Parkinson's Disease and optic atrophy

Parkinsonism Relat Disord. 2020 May:74:1-5. doi: 10.1016/j.parkreldis.2020.03.018. Epub 2020 Apr 2.

Abstract

Mutations in the gene encoding the mitochondrial carrier protein SLC25A46 are known to cause optic atrophy associated with peripheral neuropathy and congenital pontocerebellar hypoplasia. We found novel biallelic SLC25A46 mutations (p.H137R, p.A401Sfs*17) in a patient with Parkinson's disease and optic atrophy. Screening of six unrelated patients with parkinsonism and optic atrophy allowed us to identify two additional mutations (p.A176V, p.K256R) in a second patient. All identified variants are predicted likely pathogenic and affect very conserved protein residues. These findings suggest for the first time a possible link between Parkinson's Disease and SLC25A46 mutations. Replication in additional studies is needed to conclusively prove this link.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Mitochondrial Proteins / genetics*
  • Mutation
  • Optic Atrophy / diagnosis
  • Optic Atrophy / genetics*
  • Parkinson Disease / diagnosis
  • Parkinson Disease / genetics*
  • Pedigree
  • Phosphate Transport Proteins / genetics*

Substances

  • Mitochondrial Proteins
  • Phosphate Transport Proteins
  • SLC25A46 protein, human